 | • レポートコード：QYR9ST04223 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、非アルコール性脂肪性肝疾患治療薬の世界市場について調査・分析し、非アルコール性脂肪性肝疾患治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（経口、非経口）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の非アルコール性脂肪性肝疾患治療薬市場動向 ・主要企業別マーケットシェア ・非アルコール性脂肪性肝疾患治療薬の種類別市場規模2014-2019 （経口、非経口） ・非アルコール性脂肪性肝疾患治療薬の用途別市場規模2014-2019 （病院、診療所、その他） ・非アルコール性脂肪性肝疾患治療薬の北米市場：主要企業・種類別/用途別市場規模 ・非アルコール性脂肪性肝疾患治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・非アルコール性脂肪性肝疾患治療薬の中国市場：主要企業・種類別/用途別市場規模 ・非アルコール性脂肪性肝疾患治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・非アルコール性脂肪性肝疾患治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・非アルコール性脂肪性肝疾患治療薬のインド市場：主要企業・種類別/用途別市場規模 ・非アルコール性脂肪性肝疾患治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Merck、Pfizer、Novartis、GlaxoSmithKline、Allergan） ・非アルコール性脂肪性肝疾患治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Nonalcoholic fatty liver disease (NAFLD) is a condition in which excessive fatty accumulation in the hepatocytes. There are two types of NAFLD, namely simple fatty liver and non-alcoholic steatohepatitis. In simple fatty liver, the fat in the liver is very less and there is no inflammation or liver cell damage.In 2018, the global Nonalcoholic Fatty Liver Disease Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Nonalcoholic Fatty Liver Disease Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nonalcoholic Fatty Liver Disease Therapeutics development in United States, Europe and China.
The key players covered in this study
Merck
Pfizer
Novartis
GlaxoSmithKline
Allergan
…
Market segment by Type, the product can be split into
Oral
Parenteral
Market segment by Application, split into
Hospital
Clinic
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Nonalcoholic Fatty Liver Disease Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Nonalcoholic Fatty Liver Disease Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Nonalcoholic Fatty Liver Disease Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Oral
1.4.3 Parenteral
1.5 Market by Application
1.5.1 Global Nonalcoholic Fatty Liver Disease Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Nonalcoholic Fatty Liver Disease Therapeutics Market Size
2.2 Nonalcoholic Fatty Liver Disease Therapeutics Growth Trends by Regions
2.2.1 Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Regions (2014-2025)
2.2.2 Nonalcoholic Fatty Liver Disease Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Manufacturers
3.1.1 Global Nonalcoholic Fatty Liver Disease Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Nonalcoholic Fatty Liver Disease Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Nonalcoholic Fatty Liver Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Nonalcoholic Fatty Liver Disease Therapeutics Key Players Head office and Area Served
3.3 Key Players Nonalcoholic Fatty Liver Disease Therapeutics Product/Solution/Service
3.4 Date of Enter into Nonalcoholic Fatty Liver Disease Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Type (2014-2019)
4.2 Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Nonalcoholic Fatty Liver Disease Therapeutics Market Size (2014-2019)
5.2 Nonalcoholic Fatty Liver Disease Therapeutics Key Players in United States
5.3 United States Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Type
5.4 United States Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Application
6 Europe
6.1 Europe Nonalcoholic Fatty Liver Disease Therapeutics Market Size (2014-2019)
6.2 Nonalcoholic Fatty Liver Disease Therapeutics Key Players in Europe
6.3 Europe Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Type
6.4 Europe Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Application
7 China
7.1 China Nonalcoholic Fatty Liver Disease Therapeutics Market Size (2014-2019)
7.2 Nonalcoholic Fatty Liver Disease Therapeutics Key Players in China
7.3 China Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Type
7.4 China Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Application
8 Japan
8.1 Japan Nonalcoholic Fatty Liver Disease Therapeutics Market Size (2014-2019)
8.2 Nonalcoholic Fatty Liver Disease Therapeutics Key Players in Japan
8.3 Japan Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Type
8.4 Japan Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Nonalcoholic Fatty Liver Disease Therapeutics Market Size (2014-2019)
9.2 Nonalcoholic Fatty Liver Disease Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Type
9.4 Southeast Asia Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Application
10 India
10.1 India Nonalcoholic Fatty Liver Disease Therapeutics Market Size (2014-2019)
10.2 Nonalcoholic Fatty Liver Disease Therapeutics Key Players in India
10.3 India Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Type
10.4 India Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Nonalcoholic Fatty Liver Disease Therapeutics Market Size (2014-2019)
11.2 Nonalcoholic Fatty Liver Disease Therapeutics Key Players in Central & South America
11.3 Central & South America Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Type
11.4 Central & South America Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Application
12 International Players Profiles
12.1 Merck
12.1.1 Merck Company Details
12.1.2 Company Description and Business Overview
12.1.3 Nonalcoholic Fatty Liver Disease Therapeutics Introduction
12.1.4 Merck Revenue in Nonalcoholic Fatty Liver Disease Therapeutics Business (2014-2019)
12.1.5 Merck Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Nonalcoholic Fatty Liver Disease Therapeutics Introduction
12.2.4 Pfizer Revenue in Nonalcoholic Fatty Liver Disease Therapeutics Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Nonalcoholic Fatty Liver Disease Therapeutics Introduction
12.3.4 Novartis Revenue in Nonalcoholic Fatty Liver Disease Therapeutics Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Company Details
12.4.2 Company Description and Business Overview
12.4.3 Nonalcoholic Fatty Liver Disease Therapeutics Introduction
12.4.4 GlaxoSmithKline Revenue in Nonalcoholic Fatty Liver Disease Therapeutics Business (2014-2019)
12.4.5 GlaxoSmithKline Recent Development
12.5 Allergan
12.5.1 Allergan Company Details
12.5.2 Company Description and Business Overview
12.5.3 Nonalcoholic Fatty Liver Disease Therapeutics Introduction
12.5.4 Allergan Revenue in Nonalcoholic Fatty Liver Disease Therapeutics Business (2014-2019)
12.5.5 Allergan Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Nonalcoholic Fatty Liver Disease Therapeutics Key Market Segments
Table Key Players Nonalcoholic Fatty Liver Disease Therapeutics Covered
Table Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size Market Share by Type 2014-2025
Figure Oral Figures
Table Key Players of Oral
Figure Parenteral Figures
Table Key Players of Parenteral
Table Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Case Studies
Figure Clinic Case Studies
Figure Others Case Studies
Figure Nonalcoholic Fatty Liver Disease Therapeutics Report Years Considered
Table Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Nonalcoholic Fatty Liver Disease Therapeutics Market Share by Regions 2014-2019
Figure Global Nonalcoholic Fatty Liver Disease Therapeutics Market Share by Regions 2014-2019
Figure Global Nonalcoholic Fatty Liver Disease Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Nonalcoholic Fatty Liver Disease Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Nonalcoholic Fatty Liver Disease Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Nonalcoholic Fatty Liver Disease Therapeutics Market Share by Manufacturers in 2018
Table Global Nonalcoholic Fatty Liver Disease Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Nonalcoholic Fatty Liver Disease Therapeutics Product/Solution/Service
Table Date of Enter into Nonalcoholic Fatty Liver Disease Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size Share by Type (2014-2019)
Figure Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size Share by Application (2014-2019)
Figure Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Nonalcoholic Fatty Liver Disease Therapeutics Revenue Market Share by Application in 2018
Figure United States Nonalcoholic Fatty Liver Disease Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Nonalcoholic Fatty Liver Disease Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Nonalcoholic Fatty Liver Disease Therapeutics Market Share (2018-2019)
Table United States Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Nonalcoholic Fatty Liver Disease Therapeutics Market Share by Type (2014-2019)
Table United States Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Nonalcoholic Fatty Liver Disease Therapeutics Market Share by Application (2014-2019)
Figure Europe Nonalcoholic Fatty Liver Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Nonalcoholic Fatty Liver Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Nonalcoholic Fatty Liver Disease Therapeutics Market Share (2018-2019)
Table Europe Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Nonalcoholic Fatty Liver Disease Therapeutics Market Share by Type (2014-2019)
Table Europe Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Nonalcoholic Fatty Liver Disease Therapeutics Market Share by Application (2014-2019)
Figure China Nonalcoholic Fatty Liver Disease Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Nonalcoholic Fatty Liver Disease Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Nonalcoholic Fatty Liver Disease Therapeutics Market Share (2018-2019)
Table China Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Nonalcoholic Fatty Liver Disease Therapeutics Market Share by Type (2014-2019)
Table China Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Nonalcoholic Fatty Liver Disease Therapeutics Market Share by Application (2014-2019)
Figure Japan Nonalcoholic Fatty Liver Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Nonalcoholic Fatty Liver Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Nonalcoholic Fatty Liver Disease Therapeutics Market Share (2018-2019)
Table Japan Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Nonalcoholic Fatty Liver Disease Therapeutics Market Share by Type (2014-2019)
Table Japan Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Nonalcoholic Fatty Liver Disease Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Nonalcoholic Fatty Liver Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Nonalcoholic Fatty Liver Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Nonalcoholic Fatty Liver Disease Therapeutics Market Share (2018-2019)
Table Southeast Asia Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Nonalcoholic Fatty Liver Disease Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Nonalcoholic Fatty Liver Disease Therapeutics Market Share by Application (2014-2019)
Figure India Nonalcoholic Fatty Liver Disease Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Nonalcoholic Fatty Liver Disease Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Nonalcoholic Fatty Liver Disease Therapeutics Market Share (2018-2019)
Table India Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Nonalcoholic Fatty Liver Disease Therapeutics Market Share by Type (2014-2019)
Table India Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Nonalcoholic Fatty Liver Disease Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Nonalcoholic Fatty Liver Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Nonalcoholic Fatty Liver Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Nonalcoholic Fatty Liver Disease Therapeutics Market Share (2018-2019)
Table Central & South America Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Nonalcoholic Fatty Liver Disease Therapeutics Market Share by Type (2014-2019)
Table Central & South America Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Nonalcoholic Fatty Liver Disease Therapeutics Market Share by Application (2014-2019)
Table Merck Company Details
Table Merck Revenue in Nonalcoholic Fatty Liver Disease Therapeutics Business (2014-2019) (Million US$)
Figure Merck Revenue Growth Rate in Nonalcoholic Fatty Liver Disease Therapeutics Business (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Nonalcoholic Fatty Liver Disease Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Nonalcoholic Fatty Liver Disease Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Revenue in Nonalcoholic Fatty Liver Disease Therapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Nonalcoholic Fatty Liver Disease Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Nonalcoholic Fatty Liver Disease Therapeutics Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Nonalcoholic Fatty Liver Disease Therapeutics Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Allergan Company Details
Table Allergan Revenue in Nonalcoholic Fatty Liver Disease Therapeutics Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Nonalcoholic Fatty Liver Disease Therapeutics Business (2014-2019)
Table Allergan Recent Development
Table Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size Share by Regions in 2025
Figure United States Nonalcoholic Fatty Liver Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Nonalcoholic Fatty Liver Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Nonalcoholic Fatty Liver Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Nonalcoholic Fatty Liver Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Nonalcoholic Fatty Liver Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Nonalcoholic Fatty Liver Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Nonalcoholic Fatty Liver Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Product (2019-2025)
Figure Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Product in 2025
Table Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Application (2019-2025)
Figure Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
非アルコール性脂肪性肝疾患治療の世界市場：市場規模・現状・予測 Fatty liver disease refers to the accumulation of fat (triglycerides,) in the liver. The liver cell contains fats, but the accumulation of excess fat can be a cause of concern and can lead to liver inflammation known as steatohepatitis. The fatty liver can be caused by alcohol as well as can be non-…- 脂肪肝治療の世界市場：市場規模・現状・予測 Fatty liver disease is one of the most common liver dysfunction where the triglyceride fat accumulates in liver cells.The major risks associated with fatty liver disease are alcoholic cirrhosis, cardiovascular disorder, metabolic syndrome and biliary cirrhosis among others. In 2018, the global Fatty…
- 非アルコール性脂肪性肝炎（NASH）の世界市場：市場規模・現状・予測 Non-alcoholic steatohepatitis (NASH), is one of the common liver diseases, often called silent liver disease. The major feature in NASH is fat deposition in the liver, along with inflammation.NASH is projected to lead the cause of liver transplantation in the U.S. in the coming years. Some major fac…
- アルツハイマー病治療薬の世界市場：市場規模・現状・予測 Alzheimer’s disease is a neurodegenerative, progressive, non-reversible disorder. Alzheimer’s disease is caused due to abnormal functioning of brain cells i.e. failure of synaptic transmission, resulting in the loss of cognitive functions. Some of the signs and symptoms of alzheimer’s disease are me…
- 感染症治療の世界市場：市場規模・現状・予測 Infectious disease therapeutics are targeting on main infectious diseases by using drugs and vaccines to prevent, control and cure them.Major driving factors of the global infectious disease therapeutics market are favorable reimbursement policies for infectious diseases, increasing incidence of inf…